Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Mutations in certain receptors can cause diseases and offer new treatment options.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Finasteride may improve prostate cancer treatment outcomes.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain Dibenzo derivatives may help treat prostate cancer.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

DHT stops hair regrowth in mice, similar to human hair loss.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

Dutasteride and finasteride affect different cell types differently.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.